Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | -100.4% |
ROCE | 910.4% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | 5.9 |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (13.25) | (36.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (16.93) | (37.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (21.18) | (42.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (28.73) | (52.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (30.94) | (48.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 14.40 | (14.46) | (12.06)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-25 | 29.33 | (10.23) | (24.12)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 13.00 | (31.60) | (25.84)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Appointment of Chief Financial Officer | 15-Apr-2024 | 07:00 | RNS |
Approval of Warrant Terms and Conditions | 08-Apr-2024 | 07:10 | RNS |
Decisions of the Board of Directors | 08-Apr-2024 | 07:05 | RNS |
Faron Pharmaceuticals CFO stands down | 15-Apr-2024 | ShareCast |
Faron Pharmaceuticals taps Juho Jalkanen for CEO | 08-Apr-2024 | ShareCast |
Faron shares jump on encouraging trial data | 18-Mar-2024 | ShareCast |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
03-Apr-24 | Placing | Tuomo Pätsi | 128.47p | 13,333 | £17,128.73 |
03-Apr-24 | Placing | Markku Jalkanen | 128.47p | 33,333 | £42,822.45 |
Currency | UK Pounds |
Share Price | 131.25p |
Change Today | 11.25p |
% Change | 9.38 % |
52 Week High | 350.00 |
52 Week Low | 117.50 |
Volume | 1,464 |
Shares Issued | 72.01m |
Market Cap | £94.51m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 1 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
12:11 | 1,012 @ 120.15p |
09:33 | 300 @ 120.00p |
08:00 | 152 @ 117.55p |
CEO | Markku Jalkanen |
Chair | Tuomo Pätsi |
You are here: research